Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma
Clinical trial NCT05444088 · UNKNOWN
Trial details
- NCT number
- NCT05444088
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-02
- Primary completion
- 2026-06-30
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.